These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 995128)

  • 1. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Sep; 12(5):800-12. PubMed ID: 995128
    [No Abstract]   [Full Text] [Related]  

  • 2. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 3. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.
    Creese I; Burt DR; Snyder SH
    Life Sci; 1975 Sep; 17(6):933-1001. PubMed ID: 1195989
    [No Abstract]   [Full Text] [Related]  

  • 5. The search for the dopamine receptor: tribulations.
    Rotrosen J; Friedman E; Gershon S
    Psychopharmacol Commun; 1975; 1(2):229-37. PubMed ID: 4861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4376-80. PubMed ID: 1060115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and regulation of 3H-haloperidol binding to rat brain sigma receptors].
    Kizu A
    Yakubutsu Seishin Kodo; 1991 Apr; 11(2):129-39. PubMed ID: 1656649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
    Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of brain receptor binding inhibition by endogenous macromolecular substances [proceedings].
    Van Gompel P; Leysen JE
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B51-B53. PubMed ID: 6155859
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.